We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BioInvent

News List

Transgene and BioInvent Extend their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors pharmafocusasia
March 27, 2019
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors and BioInvent International AB (OMXS: BINV), a biotech company focused on the discovery and development of novel immuno-regulatory antibod
BioInvent developes Anti-TNFR2 programme for cancer treatment biospectrumasia
March 23, 2019
Using the n-CoDeR® & F.I.R.S.T.™ platforms, the company has generated a broad panel of highly specific anti-TNFR2 antibodies

Previous page 1 2 Next page